News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,462 Results
Type
Article (40365)
Company Profile (251)
Press Release (660846)
Multimedia
Podcasts (50)
Webinars (12)
Section
Business (204644)
Career Advice (2038)
Deals (35491)
Drug Delivery (96)
Drug Development (81209)
Employer Resources (172)
FDA (16262)
Job Trends (14900)
News (346055)
Policy (32658)
Tag
Academia (2577)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49543)
ALS (89)
Alzheimer's disease (1383)
Antibody-drug conjugate (ADC) (125)
Approvals (16264)
Artificial intelligence (257)
Autoimmune disease (22)
Automation (16)
Bankruptcy (362)
Best Places to Work (11665)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (179)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (279)
Cancer (2272)
Cardiovascular disease (177)
Career advice (1701)
Career pathing (30)
CAR-T (152)
Cell therapy (426)
Cervical cancer (19)
Clinical research (66093)
Collaboration (836)
Company closure (1)
Compensation (547)
Complete response letters (19)
COVID-19 (2603)
CRISPR (41)
C-suite (243)
Cystic fibrosis (100)
Data (2219)
Decentralized trials (2)
Denatured (18)
Depression (44)
Diabetes (271)
Diagnostics (6373)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (100)
Drug shortages (25)
Duchenne muscular dystrophy (94)
Earnings (86817)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112758)
Executive appointments (731)
FDA (17541)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (753)
Gene editing (106)
Generative AI (19)
Gene therapy (306)
GLP-1 (714)
Government (4437)
Grass and pollen (4)
Guidances (75)
Healthcare (18877)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (117)
Indications (29)
Infectious disease (2745)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (315)
IPO (16545)
IRA (40)
Job creations (3643)
Job search strategy (1444)
Kidney cancer (10)
Labor market (38)
Layoffs (475)
Leadership (17)
Legal (7947)
Liver cancer (76)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (307)
MASH (68)
Medical device (13511)
Medtech (13516)
Mergers & acquisitions (19491)
Metabolic disorders (689)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (93)
Neuropsychiatric disorders (27)
Neuroscience (1927)
NextGen: Class of 2025 (6543)
Non-profit (4508)
Now hiring (39)
Obesity (366)
Opinion (204)
Ovarian cancer (76)
Pain (90)
Pancreatic cancer (85)
Parkinson's disease (149)
Partnered (21)
Patents (235)
Patient recruitment (112)
Peanut (46)
People (57450)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20602)
Phase II (29102)
Phase III (21676)
Pipeline (1213)
Policy (140)
Postmarket research (2569)
Preclinical (8780)
Press Release (64)
Prostate cancer (108)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (381)
Real estate (5929)
Recruiting (65)
Regulatory (22357)
Reports (46)
Research institute (2332)
Resumes & cover letters (355)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (131)
Series B (85)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (166)
Sponsored (29)
Startups (3594)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (41)
The Weekly (30)
Vaccines (693)
Venture capitalists (41)
Weight loss (235)
Women's health (35)
Worklife (16)
Date
Today (140)
Last 7 days (942)
Last 30 days (2606)
Last 365 days (32781)
2025 (10892)
2024 (35264)
2023 (40143)
2022 (51279)
2021 (55818)
2020 (54218)
2019 (46707)
2018 (35161)
2017 (32240)
2016 (31644)
2015 (37710)
2014 (31446)
2013 (26527)
2012 (28756)
2011 (29406)
2010 (27431)
Location
Africa (725)
Alabama (54)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (37976)
Australia (6233)
California (6173)
Canada (2029)
China (525)
Colorado (267)
Connecticut (275)
Delaware (148)
Europe (81764)
Florida (916)
Georgia (207)
Idaho (57)
Illinois (539)
India (25)
Indiana (313)
Iowa (11)
Japan (164)
Kansas (104)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (899)
Massachusetts (4594)
Michigan (220)
Minnesota (393)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1741)
New Mexico (28)
New York (1758)
North Carolina (973)
North Dakota (8)
Northern California (2698)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1380)
Puerto Rico (12)
Rhode Island (33)
South America (1111)
South Carolina (23)
South Dakota (1)
Southern California (2321)
Tennessee (102)
Texas (913)
United States (23260)
Utah (183)
Virginia (146)
Washington D.C. (63)
Washington State (552)
West Virginia (3)
Wisconsin (54)
701,462 Results for "spinal elements inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Spinal muscular atrophy
6 Therapies on the Horizon for Spinal Muscular Atrophy
Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several companies—including Novartis, Scholar Rock and Biogen—progressing novel candidates through clinical trials.
March 24, 2025
·
5 min read
·
Natalia Mesa
Approvals
Roche’s Evrysdi Becomes First Pill Cleared for Spinal Muscular Atrophy
Evrysdi is the first, and so far only, noninvasive disease-modifying treatment for spinal muscular atrophy.
February 13, 2025
·
2 min read
·
Tristan Manalac
Biotech Beach
Spinal Elements® Celebrates 20 Years of Inspired Innovation
Spinal Elements, a Carlsbad, CA-based spine technology company specializing in innovative spine surgery solutions, is proud to announce its 20th anniversary.
November 9, 2023
·
3 min read
Press Releases
Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies
March 6, 2025
·
4 min read
Press Releases
Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division
January 7, 2025
·
4 min read
Policy
Providence Medical Technology, Inc. Announces FDA Clearance of CORUS™ Navigation Access System for Use with Medtronic’s StealthStation™ Surgical Navigation in Posterior Spinal Fusion
Providence Medical Technology, Inc., an innovator in solutions for spinal surgery, announces that the U.S. Food and Drug Administration has cleared the use of the CORUS™ Navigation Access System for use with the CORUS Spinal System during spinal surgery.
June 13, 2024
·
4 min read
Press Releases
Element Science Receives FDA Approval for the Revolutionary Jewel® Patch Wearable Cardioverter Defibrillator
May 2, 2025
·
4 min read
Press Releases
Elemental Machines Announces Leadership Transition: Rob Estrella Promoted to CEO
May 5, 2025
·
2 min read
Biotech Beach
Spinal Elements® Announces Full Commercial Release of Ventana® 3D-Printed Interbody Portfolio
Spinal Elements, a spine technology company, announced the full commercial launch of their Ventana 3D-Printed Interbody Portfolio: The Ventana C Anterior Cervical Interbody System, Ventana P/T Posterior Lumbar Interbody System and Ventana L Lateral Lumbar Interbody System.
November 28, 2023
·
3 min read
Business
Spinal Elements Announces Appointment of Susan Denman to the Board
Spinal Elements, a spine technology company, announced the appointment of Susan Denman to the Company’s Board of Directors.
June 20, 2023
·
3 min read
1 of 70,147
Next
